Lab automation market seen hitting $8.4 billion by 2030

The laboratory automation systems market is projected to grow from $5.85 billion in 2025 to $6.31 billion in 2026, with a broader forecast calling for $8.4 billion by 2030. Demand is being driven by more lab testing, pharma R&D and pressure to reduce errors and labor gaps.

Why it matters: - Laboratory automation is becoming more central to clinical and research labs as demand rises for faster testing, standardized results and fewer manual errors. - The market’s growth reflects a broader shift toward AI-enabled and high-throughput lab operations. - Pharma and biotech R&D spending is a major demand driver for automation tools that can speed research and improve efficiency.

What happened: - The Business Research Company released a 2026 report on the global laboratory automation systems market. - The report says the market will rise from $5.85 billion in 2025 to $6.31 billion in 2026. - The report projects the market will reach $8.4 billion by 2030. - The report forecasts a 7.4% CAGR over the forecast period. - North America held the largest market share in 2025. - Asia-Pacific is expected to grow the fastest during the forecast period.

The details: - Laboratory automation systems use specialized instruments to perform lab tasks with minimal human intervention. - The systems are designed to streamline test procedures and improve consistency in diagnostic results. - Growth in 2026 is tied to more clinical testing, standardized diagnostics, pharmaceutical research activity, a shortage of skilled lab workers and rising process complexity. - Future growth is linked to wider adoption of AI-powered lab automation, more investment in smart lab technologies, higher demand for high-throughput testing, advances in genomics and proteomics and a stronger push to reduce errors and lift efficiency. - Key trends include end-to-end automation, robotic sample handling, better data management integration, modular automation and workflow standardization. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 edition adds market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables. - The Business Research Company offers a free sample of the report More information and the full report the full report.

Between the lines: - The market outlook points to automation as a response to labor shortages and rising throughput demands, not just a technology upgrade. - The emphasis on AI, modular systems and data integration suggests buyers want lab tools that fit into larger digital workflows. - Pharma production growth in Europe adds context to why laboratory automation demand is expanding alongside industrial R&D activity. - EFPIA reported European pharmaceutical production reached €390,000 million ($422,803 million) in 2023, up from €363,300 million ($393,857 million) in 2022.

What's next: - The market is likely to keep expanding as laboratories invest in automation to handle more tests with fewer errors and less manual labor. - Growth should be strongest where clinical testing volumes, pharma research and advanced life sciences work are rising quickly. - Regional momentum will likely remain led by North America, with Asia-Pacific gaining share over time.

The bottom line: - Laboratory automation is moving from efficiency tool to core lab infrastructure, and the market forecast shows steady demand through 2030.